Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer - Test2 - elhamkhani - TriplyDB

Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer

Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer

http://www.wikidata.org/entity/Q34152848

about

The Consequences of a BRCA Mutation in Women Promoter hypomethylation, especially around the E26 transformation-specific motif, and increased expression of poly (ADP-ribose) polymerase 1 in BRCA-mutated serous ovarian cancer Poly (ADP-ribose) polymerase 1 transcriptional regulation: a novel crosstalk between histone modification H3K9ac and ETS1 motif hypomethylation in BRCA1-mutated ovarian cancer Regulation of angiotensin II type 1 receptor expression in ovarian cancer: a potential role for BRCA1 Genetic testing in hereditary breast and ovarian cancer using massive parallel sequencing Racial disparity in metabolic regulation of cancer.Practical considerations to guide development of access controls and decision support for genetic information in electronic medical records Fine mapping of 14q24.1 breast cancer susceptibility locus Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer.A novel crosstalk between BRCA1 and sirtuin 1 in ovarian cancer A prospective investigation of predictive and modifiable risk factors for breast cancer in unaffected BRCA1 and BRCA2 gene carriers.Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.BRCA1 polymorphism in breast cancer patients from Argentina.In their own words: treating very young BRCA1/2 mutation-positive women with care and caution.Glucocorticoid receptor repression mediated by BRCA1 inactivation in ovarian cancer Nicotinamide adenine dinucleotide (NAD) may affect DNA methyltransferase 1 through regulation of BRCA1 in ovarian cancer.A novel crosstalk between BRCA1 and poly (ADP-ribose) polymerase 1 in breast cancer BRCA1 as a nicotinamide adenine dinucleotide (NAD)-dependent metabolic switch in ovarian cancer The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective Clinical Pearls in breast disease Assessing Heavy Metal and PCB Exposure from Tap Water by Measuring Levels in Plasma from Sporadic Breast Cancer Patients, a Pilot Study.BRCA 1 & 2 mutations in Sudanese secondary school girls with known breast cancer in their families.A multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18-25.BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing MicroRNAs and Recent Insights into Pediatric Ovarian Cancers.A new rapid methodological strategy to assess BRCA mutational status.Effect of the BRCA1-SIRT1-EGFR axis on cisplatin sensitivity in ovarian cancer.Public Health Approaches and Barriers to Educating Providers about Hereditary Breast and Ovarian Cancer Syndrome.Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.Regulation of DNA methyltransferase 1 transcription in BRCA1-mutated breast cancer: a novel crosstalk between E2F1 motif hypermethylation and loss of histone H3 lysine 9 acetylation.BRCA1 regulates insulin-like growth factor 1 receptor levels in ovarian cancer Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers.Hereditary gynaecological malignancies: advances in screening and treatment.Li-Fraumeni syndrome: cancer risk assessment and clinical management.Should the annual pelvic examination go the way of annual cervical cytology?The molecular genetics of hereditary and sporadic ovarian cancer: implications for the future.Breast Cancer Induced by X-Ray Mammography Screening? A Review Based on Recent Understanding of Low-Dose Radiobiology Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.Precision medicine: In need of guidance and surveillance.A survey of genetic counselors about the needs of 18-25 year olds from families with hereditary breast and ovarian cancer syndrome.

P2860

Q26777891-52084D2F-094D-47D1-8FDA-3EBDC6D9CF3C Q28286269-93D30C57-BFFC-4B2A-A87A-4FF89C464B54 Q28306291-F02575E9-7234-43C9-9B60-0AE3FB2F2A25 Q33644360-00ACA780-BBA3-411C-919F-6C0EECBBC3D0 Q33903966-53A3047C-583E-402B-9D72-DD29D8D404D2 Q33906704-5253B5CD-4B6B-4183-964B-F05C235F0976 Q34065138-A756C1FE-66A3-4765-9F97-904C19B77340 Q34158088-5BC21F53-6446-49BF-9DCB-4976D644750F Q34288968-F1FE3469-C722-462D-B538-7FE9E787AA14 Q34356557-7009ABA6-E6EA-4ABB-BE1E-CA255E1E6C61 Q34630743-6027932A-F626-4D35-BA22-84D72772C521 Q34655579-2BF06F69-DFA9-4168-A386-320E6F3759EE Q34993898-11A2C2CB-2B5B-48D9-9436-00216ECA5E18 Q35105959-29EC0883-C3D7-43B5-B478-2B47F7D3D04F Q35120801-42BC6EC0-60EB-4F72-B99C-8DA5865216B3 Q35666478-5DE025B5-263E-4AA9-B44B-6E09B60575FF Q36186347-48C6D70F-F3F1-463C-B78E-D8280AEF6EAC Q36188769-72EB5252-E613-48EB-ACF1-DFB65F2455A2 Q36322846-D326FBD1-84ED-46C5-B7DB-2C2FCC983D3F Q36399021-3A1CB243-266E-42EC-984A-D1F0DD2D9F63 Q36403687-C8EFFB58-EC19-475E-B361-289706177F75 Q36471022-F37B71D4-A27B-42EB-842A-AFB2543CF731 Q36487269-FCB6C847-F272-4BE3-88CA-757D6D5CADF2 Q36738744-EEEBA55F-E982-48E7-AFD4-40D813069693 Q36804155-DDA6D319-BCF2-4534-BF97-A3E80567CA4B Q36809380-CEADDFCB-FE6B-47B0-BB2D-43FD4A70AF60 Q36878642-711160AC-824B-4267-B062-5BE175DC7A38 Q37069363-CF164A92-80EC-4873-AAC8-ECD2D6FDCF00 Q37117139-084E0CAD-6861-491C-8F4B-A3E6D88BE172 Q37607044-D02D4B22-5509-4328-8148-9481869C649F Q37720033-87489DBB-B41C-4493-BD18-8DAB6B456F34 Q37933098-971A3292-B411-47C2-9B87-E74488EE9F8E Q38067433-F356D301-4CE6-4D1B-87DB-313A466B39F7 Q38197030-05C31D4A-1756-418B-9FDB-DE92B2214C5A Q38254648-B4117F94-2C43-4C88-A8EC-40AB6E2011D3 Q38282823-79ED8AFA-122B-42B8-9C69-34BF5BA80FD8 Q38634134-6D604254-B1FE-479C-84DE-AE6E79D04F97 Q38711217-B89F7C58-6A5A-4DEA-A3C4-46922606FBCE Q42340386-68D8B555-C273-49D0-8826-8F9171D9EA8D Q42671498-1C7B2B10-9110-4DCE-95DD-1060F3AB0061

P2860

Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer

http://www.wikidata.org/entity/Q34152848

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Identification and Management ...... for Breast and Ovarian Cancer

@ast

Identification and Management ...... for Breast and Ovarian Cancer

@en

Identification and Management ...... for Breast and Ovarian Cancer

@nl

type

label

Identification and Management ...... for Breast and Ovarian Cancer

@ast

Identification and Management ...... for Breast and Ovarian Cancer

@en

Identification and Management ...... for Breast and Ovarian Cancer

@nl

prefLabel

Identification and Management ...... for Breast and Ovarian Cancer

@ast

Identification and Management ...... for Breast and Ovarian Cancer

@en

Identification and Management ...... for Breast and Ovarian Cancer

@nl

P1433

Q34152848-81F6C8E2-D3BD-48D8-BDCC-B78577D778A4

P1476

Q34152848-B38E8D0E-2B55-4726-95E8-D4E4E67DC779

P2093

Q34152848-13EE908C-2434-4055-BDD3-70D2B3A3FB04

Q34152848-6C169594-2290-40E8-A5C8-5EE6AF2A0A30

Q34152848-CEC2C4E3-DEF1-498A-AF0E-4B7A6BA27269

P2860

Q34152848-033A34C6-3145-4E7C-B2BC-A553A7CEA9E1

Q34152848-072E4CB0-DFF1-468A-84AB-A985F8784BC1

Q34152848-0B138388-5BDA-46EF-A067-F372E0B82F17

Q34152848-0BB8220E-6134-420F-B229-22C34DAC6C25

Q34152848-0F1E9F55-0BFC-47AD-88F6-34F9F78DCB95

Q34152848-117B6F51-6FF9-44A3-A12B-2E2B0F4FA463

Q34152848-1C9883B5-4DC4-4172-958E-3E27E2FEB096

Q34152848-2235E92E-56AA-4AF5-8727-6CA5495E2070

Q34152848-254EC94E-747A-4C59-89AF-1D1D8F2DD8E3

Q34152848-2634B4D3-B4F5-4B8A-A90A-3CDF741979AF

P304

Q34152848-722E96ED-4A71-4C88-A98B-3DC447E0415B

P31

Q34152848-62DFC760-6AAA-4F72-9B88-4B4E3BC3782A

Q34152848-a6f808f9-34ac-47eb-8335-97635334306a

P356

Q34152848-763C01DF-347A-4ED4-B31C-6D4B272C58BF

P407

Q34152848-2F5049A9-1E4A-479F-B59D-6AE5AEC81851

P433

Q34152848-6A2EBBAF-B97D-4A67-9F91-871AAB7C618C

P478

Q34152848-9F9C471B-98B5-4857-818E-E5E89A6FDFDF

P577

Q34152848-C9AB869D-CD03-4EF4-8119-66EDA794EBA7

P5875

Q34152848-2110E5CA-13BE-40E4-94B1-471D96751DE6

P698

Q34152848-4A900597-6B34-493E-85DB-35026B660549

P921

Q34152848-9C2676C5-522E-4CBB-B09E-072D5018CE0F

P932

Q34152848-074C2C06-0EF9-469F-9A3A-5984586F953C

P356

P1433

Mayo Clinic Proceedings

P1476

Identification and Management ...... for Breast and Ovarian Cancer

@en

P2093

Bobbie S Gostout

http://www.w3.org/2001/XMLSchema#string

Noralane M Lindor

http://www.w3.org/2001/XMLSchema#string

Sandhya Pruthi

http://www.w3.org/2001/XMLSchema#string

P2860

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks

Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers

Meta-analysis of BRCA1 and BRCA2 penetrance

Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

Cancer statistics, 2009

P304

1111-1120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4065/MCP.2010.0414

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49650845

http://www.w3.org/2001/XMLSchema#string

P698

21123638

http://www.w3.org/2001/XMLSchema#string

P921

P932

2996153

http://www.w3.org/2001/XMLSchema#string